Literature DB >> 19818400

Phenotypic changes in ciprofloxacin-resistant Staphylococcus aureus.

Lili R Mesak1, Julian Davies.   

Abstract

The work described here continues our studies of the effects of subinhibitory concentrations of antibiotics on SOS and DNA repair gene expression in Staphylococcus aureus. Mitomycin C and the new-generation fluoroquinolone moxifloxacin induced expression of SOS response genes (lexA, recA, sosA, and umuC) in a ciprofloxacin-resistant Cip(r)I strain of S. aureus. To examine phenotypic changes in Cip(r) strains mutated in CIP targets (GrlA and/or GyrA), we used Biolog Phenotype MicroArrays. Two other Cip(r) strains mutated in the norA promoter region were used to study the effects of subinhibitory concentrations of DNA-damaging antibiotics on norA expression. We show that mitomycin C and moxifloxacin induced overexpression of the norA gene in Cip(r) strains. Finally, we confirm that subinhibitory concentrations of CIP increase mutation rates in S. aureus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19818400     DOI: 10.1016/j.resmic.2009.09.013

Source DB:  PubMed          Journal:  Res Microbiol        ISSN: 0923-2508            Impact factor:   3.992


  12 in total

1.  Predictors of agr dysfunction in methicillin-resistant Staphylococcus aureus (MRSA) isolates among patients with MRSA bloodstream infections.

Authors:  Jill M Butterfield; Brian T Tsuji; Jack Brown; Elizabeth Dodds Ashley; Dwight Hardy; Kristen Brown; Alan Forrest; Thomas P Lodise
Journal:  Antimicrob Agents Chemother       Date:  2011-09-19       Impact factor: 5.191

2.  Classifying compound mechanism of action for linking whole cell phenotypes to molecular targets.

Authors:  Christina R Bourne; Nancy Wakeham; Richard A Bunce; Baskar Nammalwar; K Darrell Berlin; William W Barrow
Journal:  J Mol Recognit       Date:  2012-04       Impact factor: 2.137

3.  Impact of ciprofloxacin exposure on Staphylococcus aureus genomic alterations linked with emergence of rifampin resistance.

Authors:  Jean-Philippe Didier; Régis Villet; Elzbieta Huggler; Daniel P Lew; David C Hooper; William L Kelley; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2011-02-28       Impact factor: 5.191

4.  Vibrio cholerae triggers SOS and mutagenesis in response to a wide range of antibiotics: a route towards multiresistance.

Authors:  Zeynep Baharoglu; Didier Mazel
Journal:  Antimicrob Agents Chemother       Date:  2011-02-07       Impact factor: 5.191

5.  Subinhibitory antibiotic concentrations mediate nutrient use and competition among soil streptomyces.

Authors:  Patricia Vaz Jauri; Matthew G Bakker; Christine E Salomon; Linda L Kinkel
Journal:  PLoS One       Date:  2013-12-05       Impact factor: 3.240

6.  Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens Strains.

Authors:  Miseon Park; Fatemeh Rafii
Journal:  Int J Microbiol       Date:  2014-12-21

7.  Comparative transcription analysis and toxin production of two fluoroquinolone-resistant mutants of Clostridium perfringens.

Authors:  Sunny Park; Miseon Park; Fatemeh Rafii
Journal:  BMC Microbiol       Date:  2013-03-01       Impact factor: 3.605

8.  Concentration-dependent activity of antibiotics in natural environments.

Authors:  Steve P Bernier; Michael G Surette
Journal:  Front Microbiol       Date:  2013-02-13       Impact factor: 5.640

Review 9.  Multiple Pathways of Genome Plasticity Leading to Development of Antibiotic Resistance.

Authors:  Zeynep Baharoglu; Geneviève Garriss; Didier Mazel
Journal:  Antibiotics (Basel)       Date:  2013-05-30

10.  Action of cholecalciferol and alpha-tocopherol on Staphylococcus aureus efflux pumps.

Authors:  Saulo R Tintino; Cícera D Morais-Tintino; Fábia F Campina; Raimundo L Pereira; Maria do S Costa; Maria Flaviana B M Braga; Paulo W Limaverde; Jacqueline C Andrade; José P Siqueira-Junior; Henrique Douglas Melo Coutinho; Valdir Q Balbino; Tereza C Leal-Balbino; Jaime Ribeiro-Filho; Lucindo J Quintans-Júnior
Journal:  EXCLI J       Date:  2016-04-29       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.